Abstract
Small supernumerary marker chromosomes (sSMC) in human are present in 0.043% of newborn children. They can be defined as additional centric chromosome fragments smaller than chromosome 20. sSMC include cases with the i(18p)-, the i(12p)- (i.e. Pallister Killian-) or the inv dup(22)- (i.e. cat-eye-) syndrome. However, about 30% of the remaining sSMC are not yet correlated with clinical syndromes, mostly due to problems in comprehensive characterisation of the sSMC. Here we present an overview of the approaches for sSMC characterisation and suggest a strategy for a straightforward and comprehensive characterisation of the marker chromosomes in question.
Keywords: small supernumerary marker chromosome, esac, ring chromosome, fluorescence in situ hybridisation, classification of ssmc
Current Genomics
Title: Characterisation of Small Supernumerary Marker Chromosomes (sSMC) in Human
Volume: 5 Issue: 3
Author(s): Thomas Liehr, Kristin Mrasek, Anja Weise, Alma Kuechler, Ferdinand von Eggeling, Uwe Claussen and Heike Starke
Affiliation:
Keywords: small supernumerary marker chromosome, esac, ring chromosome, fluorescence in situ hybridisation, classification of ssmc
Abstract: Small supernumerary marker chromosomes (sSMC) in human are present in 0.043% of newborn children. They can be defined as additional centric chromosome fragments smaller than chromosome 20. sSMC include cases with the i(18p)-, the i(12p)- (i.e. Pallister Killian-) or the inv dup(22)- (i.e. cat-eye-) syndrome. However, about 30% of the remaining sSMC are not yet correlated with clinical syndromes, mostly due to problems in comprehensive characterisation of the sSMC. Here we present an overview of the approaches for sSMC characterisation and suggest a strategy for a straightforward and comprehensive characterisation of the marker chromosomes in question.
Export Options
About this article
Cite this article as:
Liehr Thomas, Mrasek Kristin, Weise Anja, Kuechler Alma, Eggeling von Ferdinand, Claussen Uwe and Starke Heike, Characterisation of Small Supernumerary Marker Chromosomes (sSMC) in Human, Current Genomics 2004; 5 (3) . https://dx.doi.org/10.2174/1389202043349354
DOI https://dx.doi.org/10.2174/1389202043349354 |
Print ISSN 1389-2029 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-5488 |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
- Announcements
Related Articles
-
Radiolabeled Oligonucleotides for Antisense Imaging
Current Organic Synthesis Identification of Novel Potent Inhibitors Against Bcl-xL Anti-apoptotic Protein Using Docking Studies
Protein & Peptide Letters Recent Advances in the Development of Novel Therapeutics Targeting Dendritic Cells
Recent Patents on Endocrine, Metabolic & Immune Drug Discovery Some Implications of Receptor Kinase Signaling Pathway for Development of Multitargeted Kinase Inhibitors
Current Radiopharmaceuticals Chemical and Potential Biological Perspectives of Genus Sarcococca (Buxaceae)
The Natural Products Journal A Phosphoproteomics Approach to Identify Candidate Kinase Inhibitor Pathway Targets in Lymphoma-Like Primary Cell Lines
Current Drug Discovery Technologies Biochemical Properties of Indoleamine 2,3-dioxygenase: From Structure to Optimized Design of Inhibitors
Current Medicinal Chemistry The PI3K Pathway at the Crossroads of Cancer and the Immune System: Strategies for Next Generation Immunotherapy Combinations
Current Cancer Drug Targets Suppressing Glioblastoma Stem Cell Function by Aldehyde Dehydrogenase Inhibition with Chloramphenicol or Disulfiram as a New Treatment Adjunct: A Hypothesis
Current Stem Cell Research & Therapy Drugging Cell Cycle Kinases in Cancer Therapy
Current Drug Targets The Use of Innovative Tools to Reproduce Human Cancer Translocations: Lessons from the CRISPR/Cas System
Current Biotechnology A Comprehensive Review on Pharmacological Properties of Abrus precatorius L.
The Natural Products Journal It Takes Two to Tango: The Structure and Function of LIM, RING, PHD and MYND Domains
Current Pharmaceutical Design The Acute Phase Protein α1-Acid Glycoprotein: A Model for Altered Glycosylation During Diseases
Current Protein & Peptide Science The Novel Role for Lyn in Integrin Signaling in Human Disease
Current Signal Transduction Therapy Novel Classes of Dimer Antitumour Drug Candidates
Current Pharmaceutical Design STAT-3 Inhibitors: State of the Art and New Horizons for Cancer Treatment
Current Medicinal Chemistry Importance of Influx and Efflux Systems and Xenobiotic Metabolizing Enzymes in Intratumoral Disposition of Anticancer Agents
Current Cancer Drug Targets Tumor Targeted Therapies: Strategies for Killing Cancer but not Normal Cells
Current Cancer Therapy Reviews Targeting Ion Channels in Leukemias: A New Challenge for Treatment
Current Medicinal Chemistry